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One prevalent trend that I continuously encountered within
my research was observing that the desired results while
the child is on medication (i.e. improved behavior in the
classroom, better grades), often jaded the parents and
teachers to where they overlooked underlying adverse
symptoms, realizing that the child could be affected much
more heavily than recognizable at first glance. Effectively
evaluating the positive effects of the medication with equal
consideration upheld for the negative symptoms that
surface would be ideal for weighing the benefits versus the
potential harms associated with ADHD treatments; however
this was almost always not the case. When a child’s
behavioral and academic patterns yield overall
improvement following treatment, most parents will still
choose to continue treatment, despite the adverse side
effects that may arise.
Eleven percent of American children are diagnosed with at
least one type of ADHD. That is 6.4 million children that are
clinically diagnosed with the inability to focus attentively,
restlessness, imbalanced mood swings and under-
developed social skills. All of these lead to any learning
environment being a daily battleground in the children both
internally as well as externally. This is caused due to an
under-activity in the frontal lobe of the child’s brain, which is
responsible for their planning, motivation, social behavior
and speech production. The symptoms associated with
ADHD are currently being combated with the utilization of
stimulants known as methylphenidates and amphetamines.
This sector of the pharmaceutical industry costs a family
seeking treatment around $2,000 annually, while society at
large spends approximately 42.5 billion for the various
treatment options available to the public coupled with those
currently being researched. But an even larger concern
remains, what are these stimulants truly doing to these
children both short and long term?
Exploration into Associations of ADHD Medications to
Academic and Behavioral Performance in Comparison to
the Adverse Side Effects.
This research consists of a mixed method approach where
both qualitative and quantitative analysis’ were used.
Quantitatively, I examined multiple accounts of studies
involving children, that both have and have not been
diagnosed with ADHD, measuring their academic
performance as well as overall body mass index over
several years with and without the use of stimulants.
Qualitatively, I will utilize previously conducted interviews
with teachers and/or parents evaluating student’s overall
behavior, personality, mental stability, as well as any
physical changes (i.e. changes in eating and sleeping
habits) based on their professional and personal
experience.
Whether the benefits outweigh the adverse side effects
associated with ADHD medications is a controversial topic
prevalent within the ADHD treatment community. Children
that are receiving clinically prescribed stimulants are often
prone to experience a loss of appetite, inconsistent
sleeping habits, and lower energy levels in order to balance
overall mood. The right course of action for parents can be
a difficult line to discern, especially with the unknown
adverse effects that could potentially influence their child’s
psyche, mental and physical development, as well as
hormonal production as a result of dependence on their
treatment. This study is an attempt towards providing
experimental validation as to how effective the stimulants
are truly improving academic performance as well as
lowering children’s tendencies to disrupt classroom
operations. The significance of these findings would
constitute for a deeper understanding for parent’s
acceptance or denial of these medications as well as to
determine whether this costly pharmaceutical industry is
genuinely producing useful, beneficial, yet safe products for
school children.
https://www.cdc.gov/ncbddd/adhd/data.html
https://chadd.org/about-adhd/general-prevalence/
http://aycnp.org/adhd_drugs.php
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The graphic displayed on the
right depicts the increase in
ADHD diagnoses in children of
different ethnicities between the
years of 1997-2014. This trend
is a product of lowering the age
a child can be diagnosed
coupled with decreasing the
severity of the behavioral
tendencies a child must exhibit
to be classified with Attention-
Deficit / Hyperactivity Disorder.
This also constitutes for today’s
statistic that one to three
children in every classroom are
diagnosed with ADHD.
